South Korean Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

ALTEOGEN

Market Cap: ₩20.8t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

D&D Pharmatech

Market Cap: ₩1.5t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

ABL Bio

Market Cap: ₩3.4t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Samsung BiologicsLtd

Market Cap: ₩72.3t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

LigaChem Biosciences

Market Cap: ₩3.9t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

QuantaMatrix

Market Cap: ₩55.8b

Operates as an in-vitro diagnostics company in South Korea.

Kyung Dong Pharmaceutical

Market Cap: ₩161.4b

Manufactures and sells pharmaceuticals in South Korea.

HLB Pharmaceutical

Market Cap: ₩267.2b

A pharmaceutical company, researches and develops peptide drugs in South Korea.

Macrogen

Market Cap: ₩169.7b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

Curocell

Market Cap: ₩447.6b

Develops CAR-T cell therapy for the treatment of cancer.

Genome

Market Cap: ₩83.6b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

Ensol Biosciences

Market Cap: ₩356.5b

A biopharmaceutical company, develops bio drugs for the treatment of degenerative disc, osteoarthritis, cancer, type 1 diabetes, and Alzheimer's dementia diseases.

PeopleBio

Market Cap: ₩54.0b

A biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases.

Prestige Biologics

Market Cap: ₩281.5b

Specializes in the development and production of biologic agents and biosimilars.

Pharmicell

Market Cap: ₩649.2b

A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.

Bridge Biotherapeutics

Market Cap: ₩49.2b

A clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.

L&C BIOLTD

Market Cap: ₩718.9b

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Ilyang PharmaceuticalLtd

Market Cap: ₩245.1b

Operates as a pharmaceutical company primarily in South Korea.

Hanall Biopharma

Market Cap: ₩1.3t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

WooGene B&G

Market Cap: ₩27.2b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

Curiox Biosystems

Market Cap: ₩554.7b

Manufactures and sells medical appliances and instruments in South Korea.

SK bioscienceLtd

Market Cap: ₩4.0t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

ORIENT BIO

Market Cap: ₩100.7b

Operates in the bio-industry in South Korea.

Kolon Life Science

Market Cap: ₩401.9b

A biotechnology company, develops cell and gene therapy products.

Eagle Veterinary TechnologyLtd

Market Cap: ₩56.3b

Manufactures and sells animal health care products.

MOA Life Plus

Market Cap: ₩75.8b

Engages in the medicine and consumer business in South Korea.

BIO-FD&CLtd

Market Cap: ₩183.9b

Develops active ingredients for anti-aging cosmetics in South Korea.

Naturalendo Tech

Market Cap: ₩117.0b

Engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea.

Kwang Dong Pharmaceutical

Market Cap: ₩225.1b

Operates as a human healthcare provider in South Korea.

Genexine

Market Cap: ₩229.2b

Operates as a biotechnology company that focuses on the development and commercialization of immunotherapies in South Korea and internationally.

GI Innovation

Market Cap: ₩1.5t

A bio-venture company, engages in the research and development of protein new drugs.

Y-Biologics

Market Cap: ₩150.7b

An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.

Optipharm.CO.LTD

Market Cap: ₩72.0b

Operates as a biomedical solution provider in South Korea.

Psomagen

Market Cap: ₩75.9b

Engages in the provision omics solutions and contract laboratory services.

MFC

Market Cap: ₩36.4b

Operates as a pharmaceutical company in South Korea.

HANDOK

Market Cap: ₩159.0b

Operates as a pharmaceutical company.